Topical Sodium Nitrite in Sickle Cell Disease and Leg Ulcers
Key facts
- Who runs it
- caterina P minniti
- Where
- Durham, Pittsburgh, and The Bronx, United StatesSee the 3 sites
- Trial code
- Status
- Terminated
- Phase
- Phase 2
- People taking part
- 18 people enrolled
- Started
- 6 Apr 2018
- Ended
- 24 Nov 2023
- Type of study
- Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- Topical Sodium Nitrite
- Placebo
- Record updated
- 7 May 2025
- Why it stopped
- Study terminated prior to achieving target enrollment due to slow recruitment and high cost of obtaining new study drug. Since no additional funds were to be available due to end of the funding period, remaining funds were expended on analyses.
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- Subjects must have a diagnosis of sickle cell disease (SS, SC, Sß-thalassemia, SD, SOArab)
- Have one or more ulcers of the one or both leg or foot
- Total surface area of leg ulcer(s) that will receive treatment must be no larger than 100 cm2
- No history of congenital methemoglobinemia
- Have documented normal Glucose-6-Phosphate Dehydrogenase (G6PD) activity
Who cannot take part
- Patients who are currently enrolled in any other investigational drug study (this does not include observational or natural history protocols)
- Use of Phosphodiesterase type 5 (PDE5) inhibitors, such as sildenafil, 4 days prior to screening
- The following list of drugs and agents may cause methemoglobinemia and should be avoided while on this study:; Anesthetics (local): Benzocaine, procaine, prilocaine, Anbesol, Orajel Antimalarials: chloroquine, primaquine, quinacrine Aniline dyes Chlorates Dapsone Diarylsulfonylureas Doxorubicin Metoclopramide Nitric and nitrous oxide Nitrobenzenes (shoe and floor polish and in paint solvents) Nitroethane (artificial nail remover, propellant, fuel additive) Nitrofurantoin (furadantin) Pyridium (phenazopyridine) Phenacetin Phenylhydrazine Rasburicase Sulfonamides (sulfacetamide, sulfamethoxazole, sulfanilamide, sulfapyridine)
- Subjects presenting with clinically diagnosed bacterial infection (e.g., osteomyelitis, pneumonia, sepsis or meningitis)
- Pregnant women - urine or serum Human chorionic gonadotropin (hCG)+ or nursing mothers
- Exposure to therapeutic nitric oxide, L-arginine, nitroprusside or nitroglycerine within the past 1 week
- Subjects who have a pre-existing methemoglobinemia (more than 3.5% on two different occasions)
Where in United States
- Duke University Medical CenterDurham, United States
- University of PittsburghPittsburgh, United States
- Montefiore Medical Center-Albert Einstein College of MedicineThe Bronx, United States
About the trial
What the trial wants to find out
The investigators are conducting a Phase II prospective and placebo controlled study of a topical cream containing sodium nitrite compared to the current standard of care. Sodium nitrite is a local donor of nitric oxide, which is known to improve blood flow and decrease bacterial load in the ulcer bed. The primary objectives are to evaluate the safety of topical sodium nitrite cream treatment in patients with sickle cell disease and chronic leg ulcers and to determine its effectiveness in accelerating the healing process and decreasing the pain associated with ulceration.
Read full original descriptionShow less
Potential benefit will be a durable resolution or improvement of the leg ulcer and its associated pain. Possible side effects include decreased blood pressure and methemoglobinemia, secondary to sodium nitrite absorption through the ulcerated skin.
Funding source FDA OOPD.
The 2 groups in the trial
- controlPlacebo, for comparison
patients will receive placebo and standard of care
Treatment: Placebo
- topical sodium nitriteTreatment being tested
patients will receive 2% topical sodium nitrite cream and standard of care
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Phase II Study of Topical Sodium Nitrite in Patients With Sickle Cell and Leg Ulcers
- Record updated
- 7 May 2025